Section ofClinical Immunology and Allergy 889 tion of immunological function was possible. In spite of normal levels of immunoglobulins no formation of specific antibodies after repeated antigenic stimulation was noted.
A distinct group of lymphopenia was described by DiGeorge et al. (1968) : in these patients multiple malformations (aplasia of thymus and parathyroids and hypoplasia of the mandibula) arise from a suppressed development of the 3rd and 4th branchial pouch. The clinical appearance in the first days of life is marked by signs of hypoparathyroidism with tetanic convulsions; if the patients survive this critical phase, lymphocytic incompetence is manifested later.
In Table 1 the criteria for a differentiation of the 3 types are listed.
In addition to these clear-cut disease entities several less well defined but similar clinical conditions have been described. The common denominator is the deficiency of distinct, but not of all immunological functions. Of the numerous theoretically possible combinations about a dozen have been observed in clinical cases. Dissociated defects of immunoglobulins have been designated as 'dysgammaglobualinemia' (Rosen et al. 1961 ) or 'dys-immunoglobulinaemia' (Stoelinga 1966 . Frequently these seem to be associated with inability to form humoral antibodies or 'antibody deficiency syndrome'. For detection of analogous deficiencies of lymphoid cells the diagnostic means are less well developed. The situation seems clear in severe lymphopenia, but functional incompetence of lymphocytes ('dyslymphocytosis') is more difficult to prove.
In general, the clinical symptomatology is less severe in the isolated dys-immunoglobulinwmias and the effect of replacement therapy is quite good. On the other hand, in all the combinations including cellular anomalies severe disease manifestations are seen that can scarcely be ameliorated by any treatment available so far.
Extensive study of patients with congenital immunodeficiencies is not only of practical value for better treatment of an individual patient, but has also contributed to the theoretical understanding of immune mechanisms in general. In mammals the thymus alone fulfils the criteria for a 'primary' or 'central' lymphoid organ (Good et al. 1966 , Miller & Osoba 1967 , Evans et al. 1967 . At a stage after its formation from the branchial endoderm it appears to act as a relay station for cells which quit the thymus for the peripheral lymphoid organs. Its function in this cellular pathway may depend upon cellular proliferation, on the generation of diversity among immunocytes or on an endocrine effect. The occurrence of immune deficiency syndromes, and the circumstance in some that foreign tissues are tolerated, afford a unique opportunity for therapy and for determining the primary sites of the defects by organ transplantation.
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In the DiGeorge syndrome it is likely that the absence of the thymus is the primary and sole cause of the immune defect (DiGeorge et al. 1968); replacement should cure. In other syndromes a histologically normal thymus probably indicates that the defect is in the peripheral lymphoid tissues; an abnormal thymus, however, such as is seen in the Swiss type of immune deficiency, may equally well be due to a defect of branchial thymic cells or to a failure, later in development, of immigrant stem cells. Either may, of course, result from an extrinsic primary ietiological event --virus infection, attack by maternal lymphocytes or a remote biochemical defect. Many vigorous attempts have been made to treat 'Swiss' immune deficiency syndrome (IDS) in particular, using either cells from blood, bone marrow or foetal liver, or by implantation of thymic tissues at various stages of maturity (Gitlin et al. 1964 , Hitzig et al. 1965 , Hathaway et al. 1965 , Harboe et al. 1966 , Miller 1967 , Cooper 1966 personal communication, Cottier 1966 personal communication, Hong 1966 personal communication, van Dooren 1966 personal communication, Kay 1968). The fact that hitherto there have been no ultimate successes may be due to the inevitable postponement of treatmenteven at birth, for example, the lymphoid tissue has a delay of about seven months of development to make upor to the effect of histo-incompatibility, that is a reaction of the grafted cells against the recipient infant. However, some evidence of partial success encourages the belief that the appropriate cells in the appropriate circumstances may yet be effective. The recorded manifestations of graft acceptance and activity include: persistence of a histologically normal thymus graft for almost a year; lymphocytosis and the advent of phytohaemagglutinin-transformable lymphocytes, some being of donor origin; the development of plasma cells and the synthesis of y-globulin, in one case of donor allotype. Skin grafts previously accepted have been rejected and delayed hypersensitivity reactions have become demonstrable. The resolution of a chronic infection, in particular moniliasis, has been welcomed as part of this immune debut, but more often adverse reactions of the graft against the host have ultimately predominated and may have accelerated the inevitable outcome.
The need for therapeutic restraint must be emphasized as regards the number and variety of cells to be transplanted; they should preferably be from a feetus at a very early stage of development and it is to be hoped that some sort of tissuetyping may soon become possible for such grafts.
Meanwhile mention should be made of the one case of thymic aplasia (DiGeorge syndrome) hitherto treated by grafting (Cleveland & Fogel 1967 personal communication) . In this case a thymus from a thirteen-week fretus was transplanted; shortly afterwards a modest lymphocytosis and a rather more dramatic eosinophilia occurred. Delayed hypersensitivity tests became positive for the first time and lymphocytes responsive to PHA were found. The child is well and thriving six months later with every hope of continuing success. Whether this is the consequence of a lucky coincidence of tissue compatibility which has hitherto eluded the victims of Swiss IDS or whether, on the other hand, it signifies a fundamental distinction between the two types of disease, remains to be seen.
